Literature DB >> 12593624

Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine.

Eric D Akin1, Eddie Perkins, Ian B Ross.   

Abstract

OBJECT: There have been significant improvements in neurovascular technology and implants over the past decade. One such material, N-butyl cyanoacrylate (NBCA), is now commercially available for cerebral arteriovenous malformation (AVM) embolization in the US. An ethylene vinyl alcohol copolymer preparation, Onyx, which is currently being evaluated, is approved for use outside North America. Although reports indicate that Onyx may be superior to NBCA from an endovascular perspective, little information exists about its surgical handling characteristics. The purpose of this study was to compare the surgical handling characteristics of Onyx-treated vessels with those of NBCA-embolized vessels in an AVM resection model.
METHODS: Fourteen pigs (two groups of seven) were anesthetized. A femoral artery was cannulated, followed by selective catheterization of the ascending pharyngeal arteries. Nidal rete mirabile (RM) embolizations were performed using either 6% Onyx or 20% NBCA. After angiographically confirmed obliteration of flow in the right RM, microsurgical resection of this structure was performed. Surgical handling characteristics of the embolized RM were rated on a scale of 1 to 5 and blood loss was recorded. Different surgeons performed the embolizations and resections. The surgeon who performed resections was blinded to the embolization agent used, and the data analysis was also performed in a blinded fashion. The surgical handling scores were superior (p < 0.05) in the Onyx-treated group. Although there was also less blood loss in this group, the difference was not significant. Subjectively, the surgeon who performed the resections believed that Onyx was softer and handled better than NBCA.
CONCLUSIONS: Onyx, which may offer endovascular advantages, also seems to provide benefits for the surgeon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12593624     DOI: 10.3171/jns.2003.98.2.0366

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  20 in total

1.  Direct endoscopic intratumoral injection of Onyx for the preoperative embolization of a recurrent juvenile nasal angiofibroma.

Authors:  A Hira; K Chao
Journal:  Interv Neuroradiol       Date:  2011-12-16       Impact factor: 1.610

2.  Basics and Principles in the Application of Onyx LD Liquid Embolic System in the Endovascular Treatment of Cerebral Arteriovenous Malformations.

Authors:  R Siekmann
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

3.  Endovascular Treatment of Cerebral AVM: Our Experience with Onyx.

Authors:  A Pérez-Higueras; R Rossi López; D Quiñones Tapia
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

4.  Transvenous Treatment of a Dural Arteriovenous Fistula of the Transverse Sinus by Embolization with Platinum Coils and Onyx HD 500+.

Authors:  R Siekmann; W Weber; B Kis; D Kühne
Journal:  Interv Neuroradiol       Date:  2005-10-26       Impact factor: 1.610

5.  Microcatheter entrapment retrieval from Onyx embolization in brain arteriovenous malformations: A technical note.

Authors:  Phat D Vu; Arthur A Grigorian
Journal:  Interv Neuroradiol       Date:  2015-07-31       Impact factor: 1.610

6.  Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.

Authors:  Naci Koçer; Hakan Hanımoğlu; Şebnem Batur; Sedat Giray Kandemirli; Osman Kızılkılıç; Zihni Sanus; Büge Öz; Civan Işlak; Mehmet Yaşar Kaynar
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

7.  The use of Onyx for embolization of peripheral vascular malformations in pediatric patients.

Authors:  Murat Cantasdemir; Fatih Gulsen; Serdar Solak; Gokce Yalcin Gulsen; Fatih Kantarci; Furuzan Numan
Journal:  Pediatr Surg Int       Date:  2012-01-22       Impact factor: 1.827

8.  Clinical Analysis of 50 Cases of BAVM Embolization with Onyx, a Novel Liquid Embolic Agent.

Authors:  Donglei Song; Bing Leng; Yuxiang Gu; Wei Zhu; Bin Xu; Xiecheng Chen; Liangfu Zhou
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

9.  Embolization of cranial dural arteriovenous fistulae with ONYX: Indications, techniques, and outcomes.

Authors:  Rashmi Saraf; Manish Shrivastava; Nishant Kumar; Uday Limaye
Journal:  Indian J Radiol Imaging       Date:  2010-02

10.  Evaluation of the toxicity of onyx compared with n-butyl 2-cyanoacrylate in the subarachnoid space of a rabbit model: an experimental research.

Authors:  Bulent Bakar; Hakan H Oruckaptan; Burcu D Hazer; Isil Saatci; Pergin Atilla; Kamer Kilic; Sevda F Muftuoglu
Journal:  Neuroradiology       Date:  2009-09-15       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.